FORMER SENIOR FBI OFFICIAL LOUIS E. GREVER JOINS INTEGENX BOARD OF DIRECTORS

PLEASANTON, Calif. – IntegenX Inc., a privately held company that is leading the emerging field of rapid human DNA identification, today announced that Louis E. Grever, former Executive Assistant Director, Science and Technology Branch of the Federal Bureau of Investigation (FBI), has joined the company’s Board of Directors. “Rapid DNA analysis is a transformative technology [...]

New Microsite Places Natural Resources Under the Microscope; Increasing the yield and efficiency of Natural Resources worldwide.

A microsite dedicated to the natural resource industries has been launched today by Carl Zeiss. The sustainable use of natural resources is dependent upon improving the efficiency of the mining, refining and end production industries. The new microsite from Carl Zeiss addresses the challenges for natural resource industries and demonstrates how pioneering microscopy solutions can [...]

Qlucore Targets The Japanese Biotech And Pharmaceutical Markets Through New Partnership With Filgen Inc

Qlucore, a world leader in the development of bioinformatics software, has today announced an agreement with Filgen, Inc, one of Japan's leading specialists in sales of science research equipment. Since its launch in 2004, Filgen has earned an international reputation for its work within the biotechnology and pharmaceutical sectors, including its highly regarded Biotechnology Analysis [...]

Applied BioCode Licenses Barcoded Magnetic Beads Technology to Douglas Scientific for High Throughput AgBio Testing

SANTA FE SPRINGS, Calif -- Applied BioCode announced today that it has signed a license agreement for its Barcoded Magnetic Bead (BMB) technology with Alexandria, Minnesota based Douglas Scientific. This non-exclusive license will give Douglas Scientific access to specific Applied BioCode BMB patents for the development of an ultra high throughput automation platform for use [...]

Bristol-Myers Squibb and Meso Scale Discovery Enter Agreement to Develop Diagnostic Assays for Alzheimer’s Disease

PRINCETON, N.J. & GAITHERSBURG, Md. -- Bristol-Myers Squibb Company (NYSE:BMY) and Meso Scale Discovery today announced they have entered an agreement to develop diagnostic assays that will measure cerebrospinal fluid biomarkers for use in Alzheimer’s disease research. Under the terms of the agreement, the companies will develop these assays based on the Meso Scale Discovery® [...]

RainDance Technologies Powers Autism Screening Panel Launched by Greenwood Genetic Center

LEXINGTON, Mass. AND CHARLOTTE, N.C.,– RainDance Technologies, Inc., the Digital Biology™ Company, today announced that Greenwood Genetic Center has commercially launched its Syndromic Autism 62-Gene Panel which was built for use on RainDance’s picodroplet-based targeted sequencing platform. The panel sequences 62 individual autosomal and X-linked genes that represent the most common single gene etiologies associated [...]

LingVitae, Plarion and KTH Royal Institute of Technology initiate a collaboration to provide DNA-based molecular testing outside central core laboratories

Stockholm, Sweden - March 28, 2012 - LingVitae, Plarion Ltd and KTH Royal Institute of Technology have today announced engagement into a collaborative development program aiming at utilising the new Discipher system for bringing DNA-based testing and diagnostics to point-of-care settings. “Our aim with the Discipher is to democratise molecular and cellular analysis, putting low-cost [...]

IDBS Delivers Platform to Accelerate Personalized Cancer Care at King’s Health Partners

London, UK, and Boston,- IDBS, a global provider of innovative data management, analytics and modeling solutions, today announced that King’s Health Partners has deployed the Oncology Research Information System (ORIS). The ground-breaking platform is the first of its kind in production and consolidates translational medicine data from multiple sites into one system. ORIS will help [...]

Tecan publishes 2011 Annual Report and notice of its Annual General Meeting

Männedorf, Switzerland, - The Tecan Group (SIX Swiss Exchange: TECN) today announced the publication of its 2011 Annual Report in the Investor Relations section of the company's website at www.tecan.com. Tecan already published its 2011 financial results in a press release and at the Press Briefing on Annual Results and Analysts' Conference held on March [...]

Innovaro Announces Completion of Licensing Agreement between Inven2 and Oxford Gene Technology

Tampa, FL – Innovaro, Inc (NYSE Amex: INV), The Innovation Solutions Company, is pleased to announce that its client Inven2, the technology transfer office at Oslo University Hospital and University of Oslo, has entered into an exclusive licensing agreement with Oxford Gene Technology (OGT) for 12 highly promising colorectal cancer tissue biomarkers through Innovaro’s Pharmalicensing [...]

Access IBO on Knowledge Center